Zero External Enzyme Cost
CBP microbes secrete their own hydrolytic enzymes, eliminating the single largest cost component after feedstock in bioethanol production.
Cellulosic Bioethanol is a sustainable biofuel derived from non-food lignocellulosic biomass, crucial for reducing reliance on fossil fuels in Biofuels (Transportation). However, its commercialization is hampered by several critical economic and technical hurdles: 1. High cost of depolymerization/hydrolysis of lignocellulosic biomass (pretreatment). 2. Lack of robust strains capable of fermenting all available sugars (C5 and C6) simultaneously. 3. Ethanol product toxicity limits final titer.
CD Biosynsis provides innovative solutions to dramatically lower production costs and increase efficiency. Our primary strategy is Consolidated Bioprocessing (CBP): Engineer yeast or bacteria to co-express cellulase and hemicellulase enzymes for one-step hydrolysis and fermentation. This eliminates the need for expensive external enzymes. Additionally, we use Pathway Engineering: Introduce a xylose metabolism pathway (e.g., xylose isomerase) into industrial yeast (S. cerevisiae) for mixed-sugar utilization. This ensures that both C5 (xylose) and C6 (glucose) sugars from the biomass are converted to ethanol, maximizing yield and efficiency.
Get a QuoteCommercial viability of Cellulosic Bioethanol is limited by these key factors:
Engineering robust strains is essential for economic viability of bioethanol.
CD Biosynsis focuses on a CBP approach to drastically cut costs and maximize conversion:
Consolidated Bioprocessing CBP
We engineer S. cerevisiae or Zymomonas mobilis to secrete functional cellulase and hemicellulase for simultaneous hydrolysis and fermentation.
Mixed C5/C6 Sugar Pathway Engineering
We introduce the efficient xylose isomerase pathway into industrial yeast to enable fermentation of both glucose C6 and xylose C5 sugars.
Enhanced Ethanol and Inhibitor Tolerance
We engineer cellular membranes and stress response pathways to withstand high ethanol titer and biomass-derived inhibitors.
High Throughput Enzyme Screening
We identify and optimize thermotolerant and highly active cellulases and hemicellulases using directed evolution and robotics.
Our solutions lead to a cost-efficient, high-yield, and industrially scalable bioethanol process.
Our Cellulosic Bioethanol engineering service offers these core benefits:
Zero External Enzyme Cost
CBP microbes secrete their own hydrolytic enzymes, eliminating the single largest cost component after feedstock in bioethanol production.
Maximized Sugar Conversion Efficiency
Enabling yeast to ferment xylose C5 and glucose C6 maximizes the conversion of total lignocellulose sugars into ethanol yield.
Lower Distillation Cost
Engineered tolerance allows the host to survive at higher ethanol concentrations, leading to a higher final titer and reduced energy use for distillation.
Robust Industrial Strains
Strains are engineered to be highly tolerant to inhibitors from biomass pretreatment, ensuring stable performance in industrial conditions.
Sustainable Non-Food Feedstock
The process utilizes agricultural waste e.g. corn stover or switchgrass rather than food crops e.g. corn grain, enhancing sustainability.
We provide the metabolic and enzymatic tools necessary to achieve cost-parity with petroleum fuels.
Our Cellulosic Bioethanol engineering service follows a rigorous CBP development workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product stability attributes.
Explore the potential for a cost-competitive, sustainable bioethanol supply. CD Biosynsis provides customized strain and process engineering solutions:
What is Consolidated Bioprocessing CBP and why is it important?
CBP integrates the three separate steps of lignocellulose conversion hydrolysis, fermentation, and enzyme production into a single process step using an engineered microbe. It is important because it eliminates the costly step of producing and adding external hydrolytic enzymes, significantly reducing the overall production cost of cellulosic ethanol.
Why is xylose fermentation so critical for cellulosic ethanol?
Lignocellulosic biomass contains approximately 30-40 percent C5 sugars, primarily xylose, along with C6 glucose. Industrial yeast S. cerevisiae naturally only ferments C6. If xylose is not fermented, up to one-third of the available carbon source for ethanol is wasted, making the process economically unfeasible.
How do you improve ethanol tolerance in the host strain?
Ethanol tolerance is improved by engineering the cell membrane composition e.g. increasing the saturation level of fatty acids to make it less permeable to ethanol and more rigid. We also modify stress response pathways that help the cell cope with membrane and protein damage caused by high ethanol concentrations.
What is the estimated project timeline?
A CBP project involving multiple enzyme expressions, xylose pathway integration, and tolerance engineering typically requires 45-60 weeks for a validated industrial strain with high ethanol titer and sugar utilization.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.